Clinical Trial Update: The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study. [Phase 4]

View source ↗

Summary

Phase 4 pilot study assessing the effect of adalimumab (Humira) on vascular abnormalities in rheumatoid arthritis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Skane University Hospital | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED